Log in | Register

Coming Clean

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Coming Clean

Is it just me, or have we entered a time where corporate scandals, and larger than life "falls from grace" are increasing common? Lately, it seems more and more sports figures, politicians, and major companies are getting caught in either illegal or immoral activities or the intentional withholding of important information – only to have their actions and misdeeds eventually revealed by the media, or other sources. This revelation is usually followed by a very public "mea culpa" with the accused holding a press conference, or appearing before Congress and admitting their mistakes and/or transgressions and promising to make things "right".

I have conveniently broken these down into three categories, with examples:

1. The sports figure accused of steriod use - the subsequent denial of such use - then the admission and apology. Example: Alex Rodriguez

2. The politician accused of extramarital infidelity - the subsequent denial - then the admission and apology. Example: John Edwards

3. The major corporation accused of suppressing important safety information - the subsequent stalling - then the admission and apology. Example: Toyota

Nothing like this would ever happen to a pharmaceutical company now would it?

We are now in the midst of GSK's very public problems relating to Avandia. Basically, the problems revolve around a report that accused the drug company of withholding information about side effects of serious heart problems, including death. At issue now is whether Avandia should be taken off the market.

Should GSK come clean and let the world know what it knew and when it knew it?

Based on similar transgressions - its the first step on the road to recovery.

 


Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

When Is Software The Answer To Regulatory Concerns About Your Investigations?

When Is Software The Answer To Regulatory Concerns About Your Investigations?

Jan 30 | John Ager, Technical Consultant, Life Science, Kepner-Tregoe, Inc

Document management software enables investigators to present the information used to reach conclusions clearly and concisely and it helps reviewers to track and approve investigations.

The Benefits of Professional Project Management

The Benefits of Professional Project Management

Jan 13 | Thorsten Vammen, Director at GEA Liquid Processing in Skanderborg, Denmark

Some companies feel that they can project manage new processing facilities themselves, bringing in sub-contracted help only when it’s needed. Self-managing is possible, but there may be a better way.

Multimedia

Government Seeking $1T Campaign Against Alzheimer's

Government Seeking $1T Campaign Against Alzheimer's

Jan 18 | Video

Government advisors tried to set priorities for a national campaign to treat and manage Alzheimer's disease, which is projected to cost more than a trillion dollars in care by 2050. But as Dr. Jon LaPook reports, the plan does not include any funding.

ADHD Drugs in Short Supply

ADHD Drugs in Short Supply

Jan 11 | Video

Parents of children with attention deficit disorders are forced to travel from pharmacy to pharmacy in search of prescription medicines with no guarantees they will be available.

Study: Link Between Statins And Diabetes

Study: Link Between Statins And Diabetes

Jan 10 | Video

A recent study reveals that women who take statins may have a greate chance of developing diabetes.

Avastin Shows Promise in Fight Against Ovarian Cancer

Avastin Shows Promise in Fight Against Ovarian Cancer

Jan 5 | Video

Two recent studies show that Avastin, already approved for other cancers - but still controversial, could help women buy more time in their fight against ovarian cancer.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter